How virtual HCT consults and NMDP℠ HLA Today
have reduced time to transplant by 8 weeks
In this case study, learn how early HLA typing through NMDP HLA Today, combined with a
telemedicine consult with a Sarah Cannon HCT physician, considerably sped up a patient’s treatment
plan, allowing the patient to potentially avoid the toxicities of additional rounds of chemotherapy or
relapse. This allows patients to move seamlessly onto the next treatment step after finishing
induction therapy—shaving up to eight weeks off the previous timeline from patient diagnosis to the
initial HCT consult at Sarah Cannon. By streamlining this process, patients have a greater chance of
undergoing stem cell transplant at the optimal time, maximizing their potential for the best possible
outcomes.
Please complete the form to
access/download the content
